新冠限制放宽后哮喘急性发作反弹:一项纵向人群研究
结果显示,2021年4月起限制放宽伴随口罩使用减少、社交活动增加,以及COVID-19、非COVID-19 ARI和重度哮喘急性发作发病率上升; incident ARI与哮喘急性发作风险升高独立相关。
要点
- 限制放宽后口罩使用减少、社交混合增加,与非COVID-19 ARI和重度哮喘急性发作反弹同步。
- 非COVID-19 ARI与哮喘急性发作风险升高独立相关(调整OR 5.75,95%CI 4.75-6.97)。
- COVID-19与哮喘急性发作的关联在奥密克戎变异株出现前后相似。
核心结论
- COVID-19限制放宽伴随口罩使用减少、社交混合增加及ARI和哮喘急性发作反弹。
- 非COVID-19 ARI与COVID-19均与重度哮喘急性发作风险升高独立相关,且关联在奥密克戎变异株出现前后相似。
研究设计与样本
- 通过每月在线问卷收集口罩使用、社交混合、 incident ARI和重度哮喘急性发作资料。
- 采用Poisson广义可加模型可视化时间趋势,多水平logistic回归检验ARI与哮喘急性发作的关联并校正混杂因素。
主要发现
- 2021年4月起限制放宽伴随口罩使用减少(p<0.001)、室内公共场所及他户访问频率增加(p<0.001)。
- 同期COVID-19发病率(p<0.001)、非COVID-19 ARI发病率(p<0.001)和重度哮喘急性发作发病率(p=0.007)上升。
- incident非COVID-19 ARI与哮喘急性发作风险升高独立相关(调整OR 5.75,95%CI 4.75-6.97)。
- incident COVID-19与哮喘急性发作风险升高相关,奥密克戎出现前OR 5.89(95%CI 3.45-10.04),之后OR 5.69(95%CI 3.89-8.31)。
临床怎么用
- 在呼吸道病毒活跃期,对哮喘患者应强调保持防护措施以减少ARI及后续急性发作风险。
- 非COVID-19 ARI与COVID-19均需被视为哮喘急性发作的重要诱因,临床评估时应关注近期感染史。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The imposition of restrictions on social mixing early in the COVID-19 pandemic was followed by a reduction in asthma exacerbations in multiple settings internationally. Temporal trends in social mixing, incident acute respiratory infections (ARI) and asthma exacerbations following relaxation of COVID-19 restrictions have not yet been described. METHODS: We conducted a population-based longitudinal study in 2312 UK adults with asthma between November 2020 and April 2022. Details of face covering use, social mixing, incident ARI and severe asthma exacerbations were collected via monthly online questionnaires. Temporal changes in these parameters were visualised using Poisson generalised additive models. Multilevel logistic regression was used to test for associations between incident ARI and risk of asthma exacerbations, adjusting for potential confounders. RESULTS: Relaxation of COVID-19 restrictions from April 2021 coincided with reduced face covering use (p<0.001), increased frequency of indoor visits to public places and other households (p<0.001) and rising incidence of COVID-19 (p<0.001), non-COVID-19 ARI (p<0.001) and severe asthma exacerbations (p=0.007). Incident non-COVID-19 ARI associated independently with increased risk of asthma exacerbation (adjusted OR 5.75, 95% CI 4.75 to 6.97) as did incident COVID-19, both prior to emergence of the omicron variant of SARS-CoV-2 (5.89, 3.45 to 10.04) and subsequently (5.69, 3.89 to 8.31). CONCLUSIONS: Relaxation of COVID-19 restrictions coincided with decreased face covering use, increased social mixing and a rebound in ARI and asthma exacerbations. Associations between incident ARI and risk of severe asthma exacerbation were similar for non-COVID-19 ARI and COVID-19, both before and after emergence of the SARS-CoV-2 omicron variant. STUDY REGISTRATION NUMBER: NCT04330599.
引用
- Tydeman, Pfeffer, Vivaldi, et al. Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK). Thorax. 2022. PMID: 36423925. doi:10.1136/thorax-2022-219591
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。